Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass

Background: Gastric bypass (GB) is an effective treatment for those who are morbidly obese with coexisting type 2 diabetes mellitus (T2DM) or non-alcoholic fatty liver disease (NAFLD). Fibroblast growth factors (FGFs) are involved in the regulation of energy metabolism. Methods: We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiun-Yu, Chen, Hsin-Hung, Lee, Wei-Jei, Chen, Shu-Chun, Lee, Shou-Dong, Chen, Chih-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839096/
https://www.ncbi.nlm.nih.gov/pubmed/35277004
http://dx.doi.org/10.3390/nu14030645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839096/
https://www.ncbi.nlm.nih.gov/pubmed/35277004
http://dx.doi.org/10.3390/nu14030645

Ejemplares similares